Top Abstract Purchase Related
Home
>
Node
>
Subnode

In vitro oocyte maturation for safer treatment of infertility. the risk of ovarian overstimulation syndrome is minimized

Hreinsson, J.; Fridström, M.

Lakartidningen 101(46): 3665-3668; 3671

2004

ISSN/ISBN: 0023-7205
PMID: 15586490
Document Number: 575719
Ovarian hyperstimulation syndrome is a well known side effect of hormone stimulation in assisted reproduction. New treatments using minimal amounts of gonadotropins or no hormone supplementation may reduce this risk. In-vitro maturation (IVM) is a treatment where final oocyte maturation is achieved in the laboratory. Results have been acceptable and this method may provide a low-risk and cost-effective alternative to traditional IVF. IVM would thus avoid the high amounts of exogenous gonadotropins required for controlled ovarian hyperstimulation. Currently, only a few teams internationally are pursuing research in this field of human reproduction. IVM is a promising treatment alternative and can be recommended especially for patients at risk of developing ovarian hyperstimulation syndrome.

Document emailed within 1 workday
Secure & encrypted payments

Sudik, R.; Fliess, F.R. 1984: Recent knowledge on follicle and oocyte maturation. 2. Oocyte development and maturation Zentralblatt für Gynakologie 106(2): 81-100
Mermillod, P.; Marchal, R. 1999: Oocyte of domestic mammals: a model for the study of in vitro maturation Contraception Fertilite Sexualite 27(6): 440-448
Lodde, V.; Modina, S.C.; Franciosi, F.; Zuccari, E.; Tessaro, I.; Luciano, A.M. 2010: Localization of DNA methyltransferase-1 during oocyte differentiation, in vitro maturation and early embryonic development in cow European Journal of Histochemistry 53(4): 199-207
Mishra, A.; Joy, K.P. 2004: Ovarian monosaccharides (glucose and fructose): hormonal effects and their role in final oocyte maturation and egg quality in catfish Heteropneustes fossilis, Bloch Indian Journal of Experimental Biology 42(11): 1084-1090
Pauthier, S.; Fernandez, H.; Lelaidier, C.; Frydman, R. 1997: Endoscopic laser CO2 treatment of infertility due to polycystic ovarian syndrome Contraception Fertilite Sexualite 25(2): 147-151
1996: Incidence of ovarian hyperstimulation syndrome following therapy of patients with infertility and the treatment and outcome Nihon Sanka Fujinka Gakkai Zasshi 48(9): 857-861
Kim, C.-H.; Ahn, J.-W.; You, R.-M.; Kim, S.-H.; Chae, H.-D.; Kang, B.-M. 2014: Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization Journal of Reproductive Medicine 59(1-2): 63-68
Chen, M.J.; Chiue, F.L.; Ho, E.S. 1993: Triplet pregnancy in premature ovarian failure after oocyte donation and in vitro fertilization: a case report and review of literature Zhonghua Yi Xue Za Zhi 51(4): 304-308
Delvigne, A.; Kostyla, K.; Murillo, D.; Van Hoeck, J.; Rozenberg, S. 2003: Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome International Journal of Fertility and Women's Medicine 48(1): 25-31
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
MacLennan, A.; Sturdee, D. 2005: Towards safer women, safer doses, safer routes and safer timing of administration of safer menopausal therapies Climacteric: the Journal of the International Menopause Society 8(1): 1-2
Eroglu, A. 1993: Experimental studies on in vitro maturation of porcine oocytes. I. Effects of medium, energy source and protein source on in vitro maturation rate Berliner und Münchener Tierärztliche Wochenschrift 106(5): 153-157
Lefèvre, B.; Gougeon, A.; Testart, J. 1990: Primates in the study of oocyte maturation Pathologie-Biologie 38(3): 166-169
Haake, K.W.; List, P.; Baier, D.; Zimmermann, G.; Pretzsch, G.; Alexander, H. 1997: Risk assessment in ovarian hyperstimulation syndrome (OHS) using the machine learning system (Decision Master) in 155 in-vitro fertilisations and embryo-transfer (IVF/ET) cycles with a long stimulation protocol Zentralblatt für Gynakologie 119(Suppl 1): 23-27
Tsutsumi, O. 1993: Studies in oocyte maturation and embryonic development Nihon Sanka Fujinka Gakkai Zasshi 45(8): 829-835
Hyttel, P.; Greve, T.; Callesen, H. 1989: Ultrastructure of oocyte maturation and fertilization in superovulated cattle Progress in Clinical and Biological Research 296: 287-297